Evidence map›Paper›PMID 2291496›Full record

ArticleAnatomy and embryology1990

Cell proliferation in developing human stomach.

D Ménard, P Arsenault

Abstract read
PubMed Publisher
In one paragraph

Article in Anatomy and embryology, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

D MénardDépartement d'Anatomie et de Biologie Cellulaire, Faculté de Médecine, Université de Sherbrooke, Québec, Canada.
P Arsenault
Université de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell proliferation during morphogenesis of human stomach was investigated using radioautography and biochemical determinations of [3H]-thymidine incorporation into DNA. Labeling indices in the epithelium, mesenchyme and muscle layer were established on radioautographs and the heights (mm) of the gastric glands were measured between 10 and 17 weeks of gestation. At 11-12 weeks, the appearance of the first pit/gland was noted, and the labeling index ranged from 9.2 to 10.2%. Labeled cells were present at all levels of the stratified epithelium. Between 14 and 16 weeks, the total epithelial labeling index declined sharply (8.1 to 5.4%) with a concomitant increase of the height of the pit/gland structures (0.055 to 0.080 mm). High proliferative activity was also recorded in the mesenchyme and the muscle layer, the labeling indices decreasing between 10 and 17 weeks. The biochemical quantitation of the [3H]-thymidine uptake into the total gastric DNA clearly supported the continuous decrease of the cell proliferation determined by radioautography. Detailed analysis of the epithelium showed that proliferative cells were more numerous at the base of the gland at the earliest stage (11 weeks) but concentrated in the pit/neck regions by 13-14 weeks. As the pit/gland development proceeded (14 to 17 weeks) labeled cells remained more abundant in the pit/neck regions of the gland (10.9%) and were rarely seen on the surface epithelium (2%). The present investigation provides basic quantitative data regarding cell proliferation in developing human stomach, and indicates that the morphogenesis of the gastric glands is correlated with the high proliferative capacity of the pit/neck cells.

Indexed as

Cell DivisionDNAEpithelial CellsEpitheliumFetusGastric MucosaHumansMesodermMicroscopy, ElectronMorphogenesisStomachThymidineTritiumDNAThymidineTritium

Identifiers

PMID2291496
OpenAlexW1976571064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.